SCHEMBL5706367

SCHEMBL5706367

Cc1cc2c(cc1O[Si](C)(C)C(C)(C)C)C(C)(C)CCC2

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
RXRA P19793 3/20 0.40
RXRB P28702 2/20 0.40
RXRG P48443 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6086554 0.78 RXRA (0.46) RXRARXRBRXRG
SCHEMBL4517231 0.76 RXRA (0.32) RXRA
SCHEMBL30573101 0.72 RXRA (0.46) RXRARXRBRXRG
SCHEMBL26607136 0.72 RXRA (0.46) RXRARXRBRXRG
SCHEMBL6666115 0.71 RXRA (0.48) RXRARXRBRXRG
SCHEMBL6330023 0.71 RXRA (0.48) RXRARXRBRXRG
SCHEMBL26607276 0.69 PPARA (0.32)
SCHEMBL4654263 0.68 RXRA (0.37) RXRARXRBRXRG
SCHEMBL5706327 0.68 RXRA (0.51) RXRARXRBRXRG
SCHEMBL6085848 0.68 HTR2A (0.46) RXRARXRBRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1696899-A1 METHODS FOR TREATING RETINOID RESPONSIVE DISORDERS USING SELECTIVE INHIBITORS OF CYP26A AND CYP26B ALLERGAN, INC. (US) 2006-09-06 EP disclosed
WO-2005058301-A1 METHODS FOR TREATING RETINOID RESPONSIVE DISORDERS USING SELECTIVE INHIBITORS OF CYP26A AND CYP26B ALLERGAN, INC. (US) 2005-06-30 WO disclosed